ATROVENT HFA Drug Patent Profile

✉ Email this page to a colleague

When do Atrovent Hfa patents expire, and what generic alternatives are available?

Atrovent Hfa is a drug marketed by Boehringer Ingelheim and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has ten patent family members in nine countries.

The generic ingredient in ATROVENT HFA is ipratropium bromide. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Atrovent Hfa

A generic version of ATROVENT HFA was approved as ipratropium bromide by RITEDOSE CORP on January 26^th, 2001.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ATROVENT HFA?
What are the global sales for ATROVENT HFA?
What is Average Wholesale Price for ATROVENT HFA?

Summary for ATROVENT HFA

International Patents:	10
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	14
Clinical Trials:	47
Patent Applications:	5,157
Drug Prices:	Drug price information for ATROVENT HFA
DailyMed Link:	ATROVENT HFA at DailyMed

Drug patent expirations by year for ATROVENT HFA

Recent Clinical Trials for ATROVENT HFA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Hat Yai Medical Education Center	Phase 3
Nationwide Children's Hospital	Phase 4
University of Nevada, Las Vegas	Phase 4

See all ATROVENT HFA clinical trials

Pharmacology for ATROVENT HFA

Drug Class	Anticholinergic
Mechanism of Action	Cholinergic Antagonists

Paragraph IV (Patent) Challenges for ATROVENT HFA

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
ATROVENT HFA	Inhalation Aerosol	ipratropium bromide	0.21 mg/Inh	021527	1	2023-12-29

US Patents and Regulatory Information for ATROVENT HFA

ATROVENT HFA is protected by one US patents.

Patents protecting ATROVENT HFA

Inhaler device
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ATROVENT HFA

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ATROVENT HFA

See the table below for patents covering ATROVENT HFA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	2009037085		⤷ Sign Up
Mexico	174127	FORMULACIONES MEDICINALES EN AEROSOL	⤷ Sign Up
South Africa	8909290		⤷ Sign Up
Hong Kong	7196	Medicinal aerosol formulations	⤷ Sign Up
Hungary	224648	Nemesacél tartály hajtógáz-adagolásos aeroszolokhoz (SPECIAL STEEL CANISTER FOR PROPELLANT-OPERATED DOSING AEROSOLS)	⤷ Sign Up
China	1095265		⤷ Sign Up
World Intellectual Property Organization (WIPO)	9413262		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration